In this week's edition, risk for cognitive decline is associated with older COVID-19 survivors; a study validates an FDA-approved blood test for traumatic brain injury; and more. Read the full coverage here: Risk for cognitive decline associated with older COVID-19 survivors Study validates FDA-approved blood test for traumatic brain injury VA hospital telestroke networks improve treatment, lower ED transfer rate Lower left atrial function associated with higher risk for dementia Rates of neurological events higher with SARS-CoV-2 infection than with COVID-19 vaccine References: Liu YH, et al. JAMA Neurol. 2022;doi:10.1001/jamaneurol.2022.0461. Papa L, et al. JAMA Netw Open. 2022;doi:10.1001/jamanetworkopen.2022.1302. Lyerly M, et al. Neurology. 2022;doi:10.1212/WNL.0000000000200143. Wang W, et al. JAMA. 2022;doi:10.1001/jama.2022.2518 Li X, et al. BMJ. 2022;doi:10.1136/bmj-2021-068373.

Ver todos los episodios